Actively Recruiting
Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak
Led by Ukrainian Society of Clinical Oncology · Updated on 2025-12-29
100
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following: Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.
CONDITIONS
Official Title
Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients who developed esophago-jejunal anastomotic leak involving less than 50% of the anastomosis circumference
- Patients who developed esophago-jejunal anastomotic leak and are stable at diagnosis with no need for diversion surgery
You will not qualify if you...
- Unstable patients with esophago-jejunal anastomotic leak
- Patients with esophago-jejunal anastomotic leak involving more than 50% of the anastomosis circumference
- Patients who refuse endoscopic vacuum therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Cancer Institute
Kyiv, Ukraine, 03022
Actively Recruiting
Research Team
O
Oleksii Dobrzhanskyi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here